Register entry

Daito Pharmaceutical Co., Ltd

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
0
Countries
1
Base
Japan
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Finished drug manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Daito Pharmaceutical Co., Ltd326 Yokamachi, Toyama-City, Toyama 939-8221, Japan (JPN)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3002806779691240774
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
-Azelastine Hydrochloridepowder60656-1839BULK INGREDIENT
Neighbours

Registered in the same town

1
Compare

Comparable companies in Japan

Enquiry

Common questions

Is Daito Pharmaceutical Co., Ltd FDA approved?
Daito Pharmaceutical Co., Ltd holds 1 FDA-registered establishment in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Daito Pharmaceutical Co., Ltd's drugs manufactured?
The FDA register lists Toyama-City. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.
What drugs does Daito Pharmaceutical Co., Ltd make?
1 product is listed under Daito Pharmaceutical Co., Ltd in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.